Target intelligence / Profile preview

Macrophage cellular machinery (None)

Target
None
Molecular classification
Other
01

Overview

Macrophages are specialized myeloid cells essential for innate immunity, tissue remodeling, and the maintenance of homeostasis. The macrophage cellular machinery encompasses the complex array of pattern recognition receptors, phagocytic apparatus, and intracellular signaling networks that allow the cell to respond to environmental cues (Nature Reviews Immunology, 2017). In chronic inflammatory diseases and cancer, this machinery is often co-opted or dysregulated, leading to the recruitment of tumor-associated macrophages (TAMs) that suppress anti-tumor immunity (Journal of Hematology & Oncology, 2021). Additionally, intracellular pathogens such as Mycobacterium tuberculosis and HIV-1 have evolved mechanisms to hijack the macrophage's phagosomal and metabolic machinery to facilitate their own survival and replication (Cell Host & Microbe, 2019). Therapeutic strategies targeting this machinery include the use of CSF1R inhibitors to reduce macrophage infiltration and CD47-SIRPα axis blockers to restore phagocytic activity against malignant cells (Frontiers in Immunology, 2020). Despite the therapeutic potential, targeting the macrophage machinery presents significant challenges, including the risk of systemic inflammation and impaired wound healing.

Other names
Macrophage functionMonocyte-macrophage systemMacrophage signaling pathwaysMacrophage polarization machinery
02

Mechanism of action

Therapeutic modulation involves inhibiting macrophage recruitment (e.g., via CSF1R or CCR2 inhibition), enhancing phagocytic activity by blocking 'don't eat me' signals (e.g., CD47-SIRPα axis), or reprogramming macrophages from an immunosuppressive M2-like state to a pro-inflammatory M1-like state using TLR agonists or cytokines.

03

Biological functions

Immune responsePhagocytosisAntigen presentationCytokine productionTissue remodelingInflammation
04

Disease associations

CancerInflammationInfectionAutoimmune diseaseAtherosclerosis
05

Safety considerations

Cytokine release syndromeSystemic immunosuppressionImpaired wound healingOff-target toxicity to tissue-resident macrophagesAnemia
06

Interacting drugs

Pexidartinib

5 more in the full profile.

07

Biomarkers

CD68CD163CD206HLA-DRiNOSArginase-1CSF1R expression

Beyond the preview

Go deeper on Macrophage cellular machinery (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Macrophage cellular machinery (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call